This brings your component doses to approximately 1.88mg GHK-Cu and 375mcg each of the other three peptides
They have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease
GHK-Cu 50MG is also commonly referenced in laboratory studies involving cutaneous, scalp, and hair-follicle cellular models used for skin and hair analysis, including fibroblasts, blood-flow-related signaling, production signals for hair follicles, matrix markers, regeneration markers, and experimental growth-phase activity, and may be evaluated alongside other peptides or GHK-Cucontaining peptide blends such as GLOW 70MG
Dosis Inyectables Rango estndar: 1-5 mg por va subcutnea de 3 a 7 veces por semana, aunque muchos protocolos favorecen las dosis ms bajas de 1-2 mg diarios
Most of these effects appear to outperform placebo
In practice, studies dissolve the peptide in sterile water or buffered media and apply it at tiny concentrations, usually somewhere between a billionth and a millionth of a mole per liter